[go: up one dir, main page]

WO2002101043A3 - Regulation of human ta4 receptor - Google Patents

Regulation of human ta4 receptor Download PDF

Info

Publication number
WO2002101043A3
WO2002101043A3 PCT/EP2002/006204 EP0206204W WO02101043A3 WO 2002101043 A3 WO2002101043 A3 WO 2002101043A3 EP 0206204 W EP0206204 W EP 0206204W WO 02101043 A3 WO02101043 A3 WO 02101043A3
Authority
WO
WIPO (PCT)
Prior art keywords
human
receptor
disorders
lio
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/006204
Other languages
French (fr)
Other versions
WO2002101043A2 (en
Inventor
Zhimin Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of WO2002101043A2 publication Critical patent/WO2002101043A2/en
Publication of WO2002101043A3 publication Critical patent/WO2002101043A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reagents that regulate human TA4 receptor and reagents which bind to human TA4 receptor gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, hematological disorders, COPD, asthma, cardiovascular disorders, CNS disorders, diabetes, obesity, cancer and genito-urinary disorders.LIO 365-Foreign Countries- 2 -LIO 365-Foreign Countries CB/ngb/NT- 1 -
PCT/EP2002/006204 2001-06-08 2002-06-06 Regulation of human ta4 receptor Ceased WO2002101043A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US29644701P 2001-06-08 2001-06-08
US60/296,447 2001-06-08
US33139301P 2001-11-15 2001-11-15
US60/331,393 2001-11-15
US37281102P 2002-04-17 2002-04-17
US60/372,811 2002-04-17

Publications (2)

Publication Number Publication Date
WO2002101043A2 WO2002101043A2 (en) 2002-12-19
WO2002101043A3 true WO2002101043A3 (en) 2003-08-28

Family

ID=27404433

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/006204 Ceased WO2002101043A2 (en) 2001-06-08 2002-06-06 Regulation of human ta4 receptor

Country Status (1)

Country Link
WO (1) WO2002101043A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003244637A1 (en) * 2002-07-16 2004-02-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr)
EP1626057A1 (en) * 2004-07-30 2006-02-15 F.Hoffmann-La Roche Ag Chimpanzee trace amine associated receptors

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000060081A1 (en) * 1999-04-06 2000-10-12 Synaptic Pharmaceutical Corporation Dna encoding orphan receptors
WO2000073449A1 (en) * 1999-05-28 2000-12-07 Synaptic Pharmaceutical Corporation Dna encoding snorf33 receptor
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors
WO2002034913A2 (en) * 2000-10-24 2002-05-02 Pe Corporation (Ny) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002042461A2 (en) * 2000-11-27 2002-05-30 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2002061075A1 (en) * 2001-02-01 2002-08-08 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000060081A1 (en) * 1999-04-06 2000-10-12 Synaptic Pharmaceutical Corporation Dna encoding orphan receptors
WO2000073449A1 (en) * 1999-05-28 2000-12-07 Synaptic Pharmaceutical Corporation Dna encoding snorf33 receptor
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors
WO2002034913A2 (en) * 2000-10-24 2002-05-02 Pe Corporation (Ny) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002042461A2 (en) * 2000-11-27 2002-05-30 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2002061075A1 (en) * 2001-02-01 2002-08-08 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ATTWOOD T K: "A compendium of specific motifs for diagnosing GPCR subtypes", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 22, no. 4, 1 April 2001 (2001-04-01), pages 162 - 165, XP004231938, ISSN: 0165-6147 *
BOROWSKY B ET AL: "Trace amines: Identification of a family of mammalian G protein-coupled receptors", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 98, no. 16, 31 July 2001 (2001-07-31), pages 8966 - 8971, XP002185201, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2002101043A2 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
WO2002101043A3 (en) Regulation of human ta4 receptor
WO2002072823A3 (en) Human g protein-coupled receptor
WO2003052088A3 (en) Regulation of human sialyltransferase
WO2002032938A3 (en) Regulation of human pgc-1-like protein
WO2003018815A3 (en) Regulation of human g protein-couple receptor kinase
WO2002042435A3 (en) Regulation of human tyrosine phosphatase
WO2002059302A3 (en) Regulation of human serotonin-like g protein-coupled receptor
WO2002031160A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002033056A3 (en) Regulation of human serine-threonine protein kinase
WO2002099107A3 (en) Regulation of human trace amine receptor ta5
WO2003000903A3 (en) Regulation of human nek-like serine/threonine protein kinase
WO2003033708A3 (en) Regulation of human serine/threonine protein kinase
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2002088362A3 (en) Regulation of human prostaglandin-f synthase 1-like protein
WO2002031161A3 (en) Regulation of human phospholipase-like enzyme
WO2002031162A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002081704A3 (en) Regulation of human protein kinase-like protein
WO2002020732A3 (en) Regulation of human map kinase phosphatase-like enzyme
WO2002036613A3 (en) Regulation of human patched-like protein
WO2003000874A3 (en) Regulation of human serine/threonine protein kinase nek3
WO2002055710A3 (en) Regulation of human purple acid phosphatase
WO2003033709A3 (en) Regulation of human serine/threonine protein kinase
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002077217A3 (en) Human dual specificity protein phosphatase 7-like protein
WO2002031125A3 (en) Human phospholipase a2-like enzyme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP